The microfluidic approach offered by this invention eliminates the problem of diffusion-based antibody-antigen binding interactions, and offers shorter reaction times. Furthermore, this invention uses small sample volumes that do not need prior purification.
[更多]
This new technology addresses the fundamental issues arising in the emerging biotechnology of gene editing, off-target effects from prolonged treatment. Specifically, this invention improves the CRISP
[更多]
| |< <- | [3589] [3590] [3591] [3592] [3593] [3594] [3595] [3596] [3597] [3598] [3599] |
